Business Context and Reporting Period
This Form 8-K Current Report was filed by cbdMD, Inc. on May 16, 2022. The filing primarily addresses significant changes in executive leadership and the execution of new employment agreements.
Key Financial Metrics
This filing does not contain periodic financial statements (e.g., revenue, profit, cash flow, or debt levels). The only financial data disclosed relates to executive compensation:
- Kevin MacDermott (New President): Annual base salary of $285,000, increasing to $350,000 upon the first positive quarterly Adjusted EBITDA.
- Equity Grants (MacDermott): 125,000 restricted stock shares and options to purchase 405,000 shares at $0.84 per share.
- T. Ronan Kennedy (CFO/COO): Granted a performance bonus of $100,000.
Material Changes
The filing reports the following material changes effective May 16, 2022:
- Departure of Scott Coffman: Mr. Coffman retired as Co-Chief Executive Officer and President. He remains on the Board of Directors and assumes the role of Vice-Chairman.
- Appointment of Kevin MacDermott: Mr. MacDermott was hired as President. He brings experience from Convergence Acceleration Solutions, LLC and ANC, Inc.
- Leadership Structure: Martin Sumichrast continues to serve as Chief Executive Officer and Chairman.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The filing does not provide updated financial guidance or market outlook. However, the compensation structure for the new President is explicitly tied to performance, with a salary increase contingent on achieving positive quarterly Adjusted EBITDA.
Compensation Risks and Contingencies:
- Severance: If terminated without cause, Mr. MacDermott is entitled to base salary for the balance of the term (minimum six months). In the event of a Change of Control or termination without cause within one year of such an event, he is entitled to 1.5x base salary or remaining base salary, whichever is greater, plus full vesting of options.
- Termination for Cause: No severance or benefits are provided if terminated for cause, upon death, or via voluntary resignation.
Investor Verification Checklist
- Verify the definition of "Adjusted EBITDA" in the company's financial reporting to assess the likelihood of the new President's salary increase.
- Review the full text of the Executive Employment Agreement (Exhibit 10.1) for specific performance goals and vesting schedules.
- Monitor subsequent filings for the impact of the leadership transition on operational strategy and financial performance.
- Confirm the vesting status and exercise price of the 405,000 stock options granted to Mr. MacDermott.